Icru-58 Recommendations For Dose Reporting: BY Pratishtha Sharma Alka Kataria Saloni Chawla
Icru-58 Recommendations For Dose Reporting: BY Pratishtha Sharma Alka Kataria Saloni Chawla
DOSE REPORTING
BY
PRATISHTHA SHARMA
ALKA KATARIA
SALONI CHAWLA
INTERSTITIAL
IMPLANTS
VOLUMES
• Tissue volume
which contains GTV In interstitial That Volume which
Gross palpable or brachy therapy is encompassed by
and microscopic
visible extent and PTV is in general an isodose surface
malignant disease.
location of identical to CTV appropriate to
• This volume
malignant growth. with very few achieve the
should be treated
adequately in order exceptions. purpose of
to achieve the aim treatment.
of therapy.
DESCRIPTION OF SOURCE PATTERNS
Essentially all implants are volume implants so it could not be used
to describe the specific implant .
A single plane implant
An implant containing two or more sources which lie in the same
plane.
In some instances, the sources lie in a single curved surface.
A two plane implant
Two planes which are generally parallel to each other.
Larger implants can often be described according to the number of
planes of sources used.
If the implant is not formed in recognizable planes,
the location of the sources relative to a plane passing through the
center of the implant or by a specific geometrical configuration (e.g.,
sphere or cylinder).
Planes
Central plane:
Plane perpendicular to the direction of the source lines.(where, source lines are
straight , parallel and of equal length.)
Within the volume of the implant, there are regions where the dose
gradient approximates a plateau.
PLATEAU REGION
The regions of plateau dose are equidistant between adjacent
neighbouring sources, for sources of identical linear activity.
They are regions of local minimum doses.
Variations in the dose between the different plateau doses can be used
t o describe the dose uniformity of an implant.
A region of plateau dose is the place where the dose can be calculated
most reproducibly and compared easily by different departments.
Prescribed Dose :
Dose defined at the time of planning by the team of radiation oncologist and
medical physicist.
Minimum Target Dose (MTD) :
Minimum dose at the periphery of the CTV.
It should be adequate to treat CTV.
It defines the treatment volume and should entirely encompass the clinical
target volume.
MINIMUM PERIPHERAL DOSE : AMERICAN CENTRES (MISNOMER)
90% of the Prescibed dose ( Manchester System For Interstitial Therapy.)
TIME DOSE
Avg. overall
Overall Instantaneous treatment dose
Irradiation time
treatment time dose rate rate
• It is the
quotient of the
• Time during • Total time • It is the total dose and
which the elapsed from the quotient of the the overall
radioactive beginning of the dose and the treatment time.
source is first irradiation to irradiation time , • It is useful for
present in the the end of last for a given continuous LDR
patient. one. fraction or pulse. irradiation with
or without
interruption.
Time Dose Pattern for Temporary Implants
PRESCRIBED DOSE
MINIMUM TARGET DOSE
MEAN CENTRAL DOSE
Additional information such as :
Dimension of high dose volume
Dimension of low dose volume
Any dose uniformity data